|
1
|
Edgeworth JD, Merante D, Patel S, Young C, Jones P, Vithlani S, Wyncoll D, Roberts P, Jones A, Den Nagata T, Ariyasu M, Livermore DM, Beale R. Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa. Clin Infect Dis 2019; 68:1932-1934. [PMID: 30418554 PMCID: PMC6522681 DOI: 10.1093/cid/ciy963] [Citation(s) in RCA: 46] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2018] [Accepted: 11/08/2018] [Indexed: 12/11/2022] Open
Abstract
Serious infections such as endocarditis due to extremely drug-resistance gram-negative bacteria are an increasing challenge. Here, we present successful adjunctive use of cefiderocol for a patient with persistently bacteremic healthcare-associated native aortic valve endocarditis due to an extended-spectrum beta-lactamase-positive Pseudomonas aeruginosa susceptible in vitro only to colistin, following failure of conventional therapeutic options.
Collapse
Affiliation(s)
- Jonathan D Edgeworth
- Department of Infectious Diseases, Guy’s Hospital, Kings College London, London, United Kingdom
| | - Domenico Merante
- Shionogi Limited, Global Clinical Development Unit, London, United Kingdom
| | - Sanjay Patel
- Shionogi Limited, Global Clinical Development Unit, London, United Kingdom
| | - Christopher Young
- Intensive Care Unit, London Bridge Hospital, HCA International, London, United Kingdom
| | - Paul Jones
- Microbiology Department, HCA International, London, United Kingdom
| | - Seema Vithlani
- Pharmacy Department, London Bridge Hospital, HCA International, London, United Kingdom
| | - Duncan Wyncoll
- Intensive Care Unit, London Bridge Hospital, HCA International, London, United Kingdom
| | - Peter Roberts
- Intensive Care Unit, London Bridge Hospital, HCA International, London, United Kingdom
| | - Andrew Jones
- Intensive Care Unit, London Bridge Hospital, HCA International, London, United Kingdom
| | | | | | - David M Livermore
- Norwich Medical School, University of East Anglia, United Kingdom
- Antimicrobial Resistance & Healthcare Associated Infections Reference Unit, Public Health England, Colindale, London
| | - Richard Beale
- School of Medicine, Guy’s Hospital, Kings College London, United Kingdom
| |
Collapse
|